I know what you are saying and am uneasy about putting my creditability on the line making optimistic predictions about cancer indications. Thus far every leading indicator points to leronlimab working in cancer though (RPs extensive CCR5 background and research with other CCR5 inhibitors, him putting his life’s work and credibility on the line and going all-in with CYDY, maraviroc success in clinical trials, outside (external RP) CCR5 research that I have read, etc.

The only concern I have is the reason for the TNBC delay so they can we can know clinical results. Hoping to get some updates later today that addresses this delay and reduces this concern. GLTU!